Acquired hemophilia A

Clinical trials for Acquired hemophilia A explained in plain language.

Never miss a new study

Get alerted when new Acquired hemophilia A trials appear

Sign up with your email to follow new studies for Acquired hemophilia A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for rare bleeding disorder: emicizumab trial launches

Disease control Ongoing

This phase 2 trial tests the drug emicizumab (Hemlibra) as a regular injection to prevent bleeding in 51 adults with acquired hemophilia A, a rare condition where the immune system attacks clotting factors. Participants receive two loading doses then weekly shots, along with stan…

Matched conditions: ACQUIRED HEMOPHILIA A

Phase 2 • Sponsor: University of Washington • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

Acquired hemophilia A

Get alerted when new Acquired hemophilia A trials appear

New hope for rare bleeding disorder: emicizumab trial launches